Opioids use in cancer pain management-Views of oncologists
Not Applicable
- Registration Number
- CTRI/2022/04/042087
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a) Trained Oncologists
b) Practicing Consultant level practice
c)Cancer hospitals or tertiary hospitals with cancer care services, including both Govt and private
hospitals.
Exclusion Criteria
a)Trainee oncologists
b)Standalone Private oncology clinics
not attached to hospitals
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To develop a complex, multifaceted, nuanced explanation for facilitators and barriers for opioid <br/ ><br>use by the oncologists in the setting of cancer pain management, which will help explore <br/ ><br>oncologists gatekeeping behavior that impacts opioids access.Timepoint: 6,12,18,24 months
- Secondary Outcome Measures
Name Time Method To inform policies and develop education modules that would facilitate opioid use by an <br/ ><br>oncologist�s.Timepoint: 24, 32 months;To know the views of oncologists on opioids usage for cancer pain management.Timepoint: 12,18,24 months